Short answer
Humana (HUM) filed an 8-K current report with the SEC on April 29, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Q1 2026 financial results for quarter ended March 31, 2026.
Humana 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Q1 2026 financial results for quarter ended March 31, 2026
- Detailed earnings release available as Exhibit 99.2 and on Humana’s Investor Relations website
- Management remarks include future earnings expectations, creating potential guidance-related market impact
Item EX-99.1 · Exhibit EX-99.1
- 1Q26 GAAP EPS $9.83 and adjusted EPS $10.31, with adjusted results at the high end of guidance
- GAAP FY2026 EPS guidance cut to at least $8.36 from $8.89, while adjusted guidance held at least $9.00
- Insurance benefit ratio 89.4% versus guidance just under 90%, supporting affirmed FY2026 guidance of 92.75% ±25 basis points
- Medicare Advantage membership growth target maintained at approximately 25%, despite Star Ratings pressure and lower quality bonus payments
- Insurance leadership transition advances June 29, with Aaron Martin succeeding George Renaudin as Insurance Segment President
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Humana 8-K filings
Get the next HUM 8-K as it lands
Follow HUM for push alerts, or ask the research agent what this filing means.